ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 440

Comparison of C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) with Estimated Glomerular Filtration Rate (eGFR) in Patients with Rheumatoid Arthritis (RA)

Ilias Oikonomopoulos1 and John D. Carter2, 1Internal Medicine; Division of Rheumatology, University of South Florida Morsani College of Medicine, Tampa, FL, 2Internal Medicine; Division of Rheumatology, University of South Florida, Tampa, FL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: C-reactive protein (CRP) and renal disease

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: It has previously been demonstrated that the ESR and CRP correlate in patients with RA but with a high degree of variability.  Reasons for this variability are not completely understood, but anemia, adiposity, and age can play a role. It has previously been suggested that ESR and CRP are inversely related to renal function in a non-RA population; it is felt that underlying inflammation is the explanation for the negative correlation with the CRP, specifically.  The aim of this study is to see if the CRP and/or ESR inversely correlate with renal function in patients with RA.  

Methods: This is a retrospective chart review of RA patients followed at USF Health.  Subjects were identified by ICD-9 code (714.0) and they had to have a CRP, ESR, hemoglobin (Hgb) and eGFR performed on the same day.  The most recent labs were utilized and no patient was included twice.  Patients were excluded if they were <18 years of age or had a history of blood cancers known to affect inflammatory markers.  The co-primary endpoints were the correlation between CRP and eGFR as well as ESR and eGFR.  Secondary endpoints included correlation between CRP and ESR as well as both inflammatory markers with Hgb and the patients’ age.  Spearman correlation coefficients (rho) were utilized to determine significance.   

Results: 158 patients met the inclusion criteria; 136 (86%) were females with a mean age of 58.82 years (+/- 11.44 SD; range 26-84 years).  93/130 (71.5%) of these subjects were seropositive; status was unknown on 28 patients.  The mean CRP and ESR in these subjects was 0.89mg/dL (+/- 1.37mg/dL SD) and 16.07mmHg (+/- 16.61mmHg SD), respectively; the mean eGFR and Hgb was 82.76 mL/min/1.73m2 (+/- 20.92 mL/min/1.73m2  SD) and 12.77g/dL (+/- 1.31g/dL SD), respectively.  There was no correlation between the CRP and the eGFR (rho = 0.041; p = 0.60) [Fig 1]; there was also no correlation between the ESR and the eGFR (rho = -0.037; p = 0.64) [Fig 1].  There was a correlation between the CRP and ESR but with a high degree of variability (rho = 0.596; p < 0.0001) [Fig 1].  The ESR correlated weakly with Hgb and it did so in an inverse fashion (rho = -0.348; p<0.0001); the CRP did not appear to correlate with the Hgb (rho = -0.115; p = 0.15).  There was no correlation with either CRP or ESR and age (rho = -0.075 and 0.006 respectively). 

Conclusion: This retrospective chart review of 158 patients with RA suggests there is no correlation between CRP and/or ESR with renal function.  Renal function does not appear to be an explanation for some of the variability that is documented between CRP and ESR in patients with RA.


Disclosure:

I. Oikonomopoulos,
None;

J. D. Carter,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-c-reactive-protein-crp-and-erythrocyte-sedimentation-rate-esr-with-estimated-glomerular-filtration-rate-egfr-in-patients-with-rheumatoid-arthritis-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology